CircVAPA promotes aggressive phenotypes of NSCLC cells by the miR-876-5p/WNT5A axis activating Wnt/beta-catenin signaling.
CircVAPA exerts oncogenic property in non-small cell lung cancer by the miR-876-5p/WNT5A axis.